Menu Back to Event-Details

Value and Access – How Do We Strike a Balance between Both?

Track:
What are Necessary Steps towards Outcome-Driven Health Systems?

Day & Time:
April 19, 8:30AM - 10:00AM (Central Europe Standard Time)

Session Number:
S0204

Type:
Session

Title:
Value and Access – How Do We Strike a Balance between Both?

Chair(s):
Indranil Bagchi, PhD, MS
Vice President and Franchise Head, Global Value and Access
Novartis Oncology, United States

Description:
Value and Access – How Do We Strike a Balance between Both?

Presentation(s) & Speaker(s):
Managed Access Agreements – A New Frontier in Germany?
Evert Jan van Lente
Director EU-Affairs
AOK Bundesverband (Federal Insurer), Germany

Outcome Focussed Access Agreements: Payer Perspectives
Edmund Jessop, DrMed
Medical adviser at NHS England
National Health Service, United Kingdom

Factors Leading to Difference between Regulatory and Market Access Decisions for Drugs in Six Cancers Internationally
Jan McKendrick
Senior Director
PRMA Consulting Ltd, United Kingdom